Softwr

Healthcare · head to head

Cerner PowerChart vs Therapixel

Cerner PowerChart logo

Cerner PowerChart

Healthcare

Advanced clinical charting and documentation system within Cerner EHR

From
On request
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Cerner PowerChart no publicly published pricing rates available; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Cerner PowerChart covers Clinical Documentation, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Cerner PowerChart and Therapixel actually diverge.

Attributes where Cerner PowerChart and Therapixel differ
AttributeCerner PowerChartTherapixel
PlatformsWeb, DesktopWeb
Founded1979Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Cerner PowerChart

  • Clinical Documentation
  • Intelligent Templates
  • Evidence-Based Content
  • Clinical Decision Support
  • Workflow Automation
  • Real-time Alerts
  • HL7
  • FHIR

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Cerner PowerChart

  • Patient Carenot Therapixel
  • Medical Recordsnot Therapixel
  • Practice Managementnot Therapixel
  • Telehealthnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Cerner PowerChart
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Cerner PowerChart
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Cerner PowerChart
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Cerner PowerChart

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Cerner PowerChart

  • No publicly published pricing rates available

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Cerner PowerChart

On request

No published plan breakdown. See the Cerner PowerChart review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Cerner PowerChart if

  • You need clinical documentation.
  • You work on Web, Desktop.
  • You also want intelligent templates.
Cerner PowerChart review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Cerner PowerChart or Therapixel better?
Neither clearly leads. Cerner PowerChart starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Cerner PowerChart or Therapixel?
Cerner PowerChart starts at On request and Therapixel at On request.
Does Cerner PowerChart or Therapixel run on more platforms?
Cerner PowerChart runs on Web, Desktop. Therapixel runs on Web.
What is Cerner PowerChart best used for?
Cerner PowerChart is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Therapixel is typically brought in for.
What can Cerner PowerChart do that Therapixel cannot?
Cerner PowerChart covers Clinical Documentation, Intelligent Templates, Evidence-Based Content, Clinical Decision Support. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Cerner PowerChart: What is Cerner PowerChart pricing?

Cerner PowerChart, now part of Oracle Health, does not publish standard pricing. Enterprise healthcare EHR solutions require custom pricing based on hospital size, bed count, and module selection. Contact Oracle Health sales for quotes.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Cerner PowerChart: How do I get a demo or pricing information for Oracle Health?

Oracle Health provides a contact form and demo request option on its website. You can request a demo or contact the sales team to discuss your healthcare organization's needs and receive pricing information.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Cerner PowerChart

More on Therapixel

Keep looking

Other head to heads